Financial Performance - The Group's revenue for the six months ended September 30, 2022, was approximately HK$211.9 million, an increase of approximately HK$12.2 million or 6.1% compared to HK$199.7 million for the same period in 2021[11]. - Profit attributable to the owners of the Company was approximately HK$3.4 million for the six months ended September 30, 2022, a significant decrease from approximately HK$53.9 million for the same period in 2021[11]. - Total comprehensive income for the period was HK$3.3 million, down from HK$54.0 million in the previous year[13]. - Basic and diluted earnings per share attributable to ordinary equity holders of the Company were HK$0.85 cents, a decrease from HK$13.48 cents in the same period last year[13]. - The Group reported a profit before tax of HK$4.3 million, a decrease from HK$60.6 million for the same period in 2021[13]. - The Group received government subsidies of HK$6,678,000 during the six months ended September 30, 2022, primarily under the Employment Support Scheme[79]. - The total tax charge for the period was HK$900,000, a decrease of 86.5% compared to HK$6,648,000 in the same period last year[89]. - Profit for the period was approximately HK$3.4 million, down by HK$50.5 million, or 94%, from HK$53.9 million in the previous period[123][126]. Revenue Breakdown - Revenue from external customers for the six months ended September 30, 2022, was HK$211,900,000, an increase of 6.6% from HK$199,730,000 in 2021[51]. - Revenue from treatment services decreased to HK$153,569,000, down 13.0% from HK$176,594,000 in the previous year[62]. - Revenue from skin care products significantly increased to HK$58,120,000, up 154.5% from HK$22,775,000 in 2021[62]. - The geographical breakdown of revenue showed HK$203,124,000 from Hong Kong and HK$8,776,000 from Mainland China for the six months ended September 30, 2022[51]. Expenses and Costs - The cost of inventories and consumables was HK$18.99 million for the period[13]. - Staff costs amounted to HK$13.3 million during the six months ended September 30, 2022[13]. - Property rentals and related expenses totaled HK$82.4 million, an increase from HK$56.4 million in the previous year[13]. - Depreciation charge for property, plant and equipment amounted to approximately HK$21.7 million, representing 10.2% of total revenue for the Period Under Review, compared to approximately HK$7.3 million or 3.7% for the Previous Period[141]. - Other expenses, net increased by approximately HK$10.0 million or 22.8%, from approximately HK$43.9 million for the Previous Period to approximately HK$53.9 million for the Period Under Review[141]. Assets and Liabilities - Total non-current assets decreased from HK$276,708,000 to HK$264,837,000, a decline of approximately 4.0%[16]. - Current assets increased from HK$200,106,000 to HK$235,951,000, representing a growth of about 17.9%[16]. - Total current liabilities increased from HK$202,994,000 to HK$235,656,000, reflecting a rise of about 16.0%[16]. - Net assets increased from HK$171,270,000 to HK$174,579,000, a growth of approximately 1.8%[19]. - Cash and cash equivalents increased from HK$65,680,000 to HK$80,802,000, a rise of about 22.9%[16]. - Inventories increased from HK$37,969,000 to HK$45,160,000, representing a growth of approximately 19.0%[16]. - Lease liabilities decreased from HK$89,587,000 to HK$76,877,000, a reduction of approximately 14.2%[19]. Operational Insights - The Group is primarily engaged in providing medical aesthetic services and selling skin care products[30]. - The Group's reportable operating segment is the non-surgical medical aesthetic services segment, primarily engaged in providing medical aesthetic services and selling skin care products in Hong Kong and Mainland China[45]. - The Group's strategy focuses on customer needs, aiming to enhance brand reputation and service quality in the high-end medical aesthetics sector[164]. - The Group aims to maintain high service quality and competitiveness by continuing to invest in staff training[164]. - The Group will keep optimizing the environment and services of its medical aesthetic and beauty treatment centers to reinforce its market position[163]. Future Outlook - The Group is cautiously optimistic about its prospects as the pandemic stabilizes and the government eases anti-pandemic measures[163]. - The Group plans to launch new XOVE product lines in 2023 and has entered into an agreement with an international beauty retail group to establish a presence in over 300 offline retail outlets in Mainland China[169]. - The Group expects the operating environment to improve as the number of visitors to Hong Kong is anticipated to increase steadily[170]. Shareholding and Governance - As of September 30, 2022, Ms. Lai Ka Yee Gigi holds 275,000,000 shares, representing 68.75% of the company's issued share capital[189]. - Mrs. Gigi Ma is deemed to be interested in 100% of the issued share capital of Sunny Bright, due to her spouse's ownership of the remaining shares[198]. - No other directors or chief executives registered any interests or short positions in the shares, underlying shares, or debentures of the company or its associated corporations as of September 30, 2022[199].
卓珈控股(01827) - 2023 - 中期财报